2007
DOI: 10.1016/j.freeradbiomed.2006.11.013
|View full text |Cite
|
Sign up to set email alerts
|

Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
69
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(72 citation statements)
references
References 47 publications
3
69
0
Order By: Relevance
“…Moreover, the results obtained in our animal model are also in line with the active implication of NADPH oxidases in the apoptotic death induced by doxorubicin to cardiomyocytes in vitro reported by Gilleron et al, (2009). Nox2 and Nox4 are the major isoforms of Nox expressed in cardiac tissue (Santos et al 2011), but previous works have pointed out that Nox2 is the isoform activated in doxorubicin cardiotoxicity (Deng et al 2007;Yoshida et al 2009;Huelsenbeck et al 2011) as well as in cardiac hypertrophy (Santos et al, 2011;Takemoto et al, 2001). Our results exclude up-regulation of the expression of the main Nox2 subunits gp91phox and p22phox, but it is to be noted that recruitment of cytosolic subunits of Nox2 expressed in heart tissue can lead to the observed activation of this enzyme by doxorubicin treatment, as pointed out by Yoshida et al, 2009 and Huelsenbeck et al, 2011.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, the results obtained in our animal model are also in line with the active implication of NADPH oxidases in the apoptotic death induced by doxorubicin to cardiomyocytes in vitro reported by Gilleron et al, (2009). Nox2 and Nox4 are the major isoforms of Nox expressed in cardiac tissue (Santos et al 2011), but previous works have pointed out that Nox2 is the isoform activated in doxorubicin cardiotoxicity (Deng et al 2007;Yoshida et al 2009;Huelsenbeck et al 2011) as well as in cardiac hypertrophy (Santos et al, 2011;Takemoto et al, 2001). Our results exclude up-regulation of the expression of the main Nox2 subunits gp91phox and p22phox, but it is to be noted that recruitment of cytosolic subunits of Nox2 expressed in heart tissue can lead to the observed activation of this enzyme by doxorubicin treatment, as pointed out by Yoshida et al, 2009 and Huelsenbeck et al, 2011.…”
Section: Discussionmentioning
confidence: 99%
“…Since Deng et al, (2007) have pointed to Nox2, composed of the catalytic subunit gp91phox and the membrane binding partner p22phox, as the most probable isoform activated in the cardiotoxic process, we have performed Western blotting analysis of the heart homogenates using antigp91phox (cat. number 611415 from BD Transduction Laboratories, Lexington, KY, USA) and anti-p22phox (cat.…”
Section: C Of Supplementary Data)mentioning
confidence: 99%
“…Maytin et al have indicated that myocardial hypertrophy induced by chronic pressure overload after aortic constriction was also not affected in gp91 phox knockout mice (43). However, another study has shown the reduced cardiotoxicity following doxorubicin treatment in gp91 phox knockout mice (44). Taking together, these studies suggest that gp91 phox has different functions in cardiac remodeling depending on the nature of cardiac damage.…”
Section: Discussionmentioning
confidence: 99%
“…As a model system we used doxorubicin (dox), a potent inducer of superoxide in cardiomyocytes (10). The production of superoxide by dox is catalyzed by NADPH oxidase (Nox) enzymes, which are important mediators of dox cardiotoxicity in vivo (11).…”
Section: Snornasmentioning
confidence: 99%